Return on Investments: An indicator of how profitable a company is relative to its assets invested by shareholders and long-term bond holders. Calculated by dividing a company's operating earnings by its long-term debt and shareholders equity. Calculated as: Income from Continuing Operations / (Total Long-Term Debt + Shareholders Equity)
Teva Pharmaceutical Industries Ltd. (TEVA) had Return on Investments of 1.20% for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
$4.18B |
|
$282.00M |
|
$2.07B |
|
$2.10B |
|
$3.72B |
|
$455.00M |
|
$-252.00M |
|
$203.00M |
|
$203.00M |
|
$281.00M |
|
$282.00M |
|
$283.00M |
|
$281.00M |
|
$455.00M |
|
$705.00M |
|
1.15B |
|
1.16B |
|
$0.25 |
|
$0.24 |
|
| Balance Sheet Financials | |
$12.62B |
|
$4.81B |
|
$27.51B |
|
$40.13B |
|
$11.86B |
|
$16.76B |
|
$21.44B |
|
$33.30B |
|
$6.83B |
|
$-13.26B |
|
$6.83B |
|
1.15B |
|
| Cash Flow Statement Financials | |
$122.00M |
|
$437.00M |
|
$-1.74B |
|
$3.30B |
|
$2.16B |
|
$-1.14B |
|
$72.00M |
|
$-340.00M |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.06 |
|
-- |
|
-- |
|
0.71 |
|
2.52 |
|
50.34% |
|
10.90% |
|
10.90% |
|
-- |
|
4.86% |
|
6.75% |
|
$-75.00M |
|
-- |
|
-- |
|
-- |
|
0.10 |
|
0.59 |
|
1.17 |
|
76.81 |
|
4.13% |
|
-2.13% |
|
0.70% |
|
|
Return on Investments |
1.20% |
$5.96 |
|
$-0.06 |
|
$0.11 |
|